These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 22267765

  • 1. Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity.
    Schuurhof A, Bont L, Hodemaekers HM, de Klerk A, de Groot H, Hofland RW, van de Pol AC, Kimpen JL, Janssen R.
    Eur Respir J; 2012 Jun; 39(6):1475-81. PubMed ID: 22267765
    [Abstract] [Full Text] [Related]

  • 2. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.
    Elliott MB, Welliver RC, Laughlin TS, Pryharski KS, LaPierre NA, Chen T, Souza V, Terio NB, Hancock GE.
    J Med Virol; 2007 Apr; 79(4):447-56. PubMed ID: 17311330
    [Abstract] [Full Text] [Related]

  • 4. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus.
    Larrañaga CL, Ampuero SL, Luchsinger VF, Carrión FA, Aguilar NV, Morales PR, Palomino MA, Tapia LF, Avendaño LF.
    Pediatr Infect Dis J; 2009 Oct; 28(10):867-73. PubMed ID: 19738511
    [Abstract] [Full Text] [Related]

  • 5. Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis.
    Wilson J, Rowlands K, Rockett K, Moore C, Lockhart E, Sharland M, Kwiatkowski D, Hull J.
    J Infect Dis; 2005 May 15; 191(10):1705-9. PubMed ID: 15838798
    [Abstract] [Full Text] [Related]

  • 6. Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells.
    Hirakawa S, Kojima T, Obata K, Okabayashi T, Yokota S, Nomura K, Obonai T, Fuchimoto J, Himi T, Tsutsumi H, Sawada N.
    J Med Virol; 2013 Dec 15; 85(12):2141-50. PubMed ID: 24009192
    [Abstract] [Full Text] [Related]

  • 7. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
    Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M.
    Pediatrics; 2005 Jan 15; 115(1):e7-14. PubMed ID: 15629968
    [Abstract] [Full Text] [Related]

  • 8. Nasal lavage leukotrienes in infants with RSV bronchiolitis.
    Da Dalt L, Callegaro S, Carraro S, Andreola B, Corradi M, Baraldi E.
    Pediatr Allergy Immunol; 2007 Mar 15; 18(2):100-4. PubMed ID: 17338781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High concentrations of amniotic fluid proinflammatory cytokines in healthy neonates are associated with low risk of respiratory syncytial virus bronchiolitis.
    Houben ML, Rovers MM, Wilbrink B, Belderbos ME, Bloemen-Carlier EM, Visser GH, Kimpen JL, Bont L.
    Pediatr Infect Dis J; 2012 Sep 15; 31(9):931-4. PubMed ID: 22699404
    [Abstract] [Full Text] [Related]

  • 11. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.
    McNamara PS, Flanagan BF, Hart CA, Smyth RL.
    J Infect Dis; 2005 Apr 15; 191(8):1225-32. PubMed ID: 15776367
    [Abstract] [Full Text] [Related]

  • 12. Exhaled nitric oxide in acute respiratory syncytial virus bronchiolitis.
    Gadish T, Soferman R, Merimovitch T, Fireman E, Sivan Y.
    Arch Pediatr Adolesc Med; 2010 Aug 15; 164(8):727-31. PubMed ID: 20679163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.
    Bont L, Kimpen JL.
    Intensive Care Med; 2002 May 15; 28(5):616-21. PubMed ID: 12029411
    [Abstract] [Full Text] [Related]

  • 15. Moderate local and systemic respiratory syncytial virus-specific T-cell responses upon mild or subclinical RSV infection.
    de Waal L, Koopman LP, van Benten IJ, Brandenburg AH, Mulder PG, de Swart RL, Fokkens WJ, Neijens HJ, Osterhaus AD.
    J Med Virol; 2003 Jun 15; 70(2):309-18. PubMed ID: 12696123
    [Abstract] [Full Text] [Related]

  • 16. Plasma interferon-gamma, interleukin-10 and soluble markers of immune activation in infants with primary adenovirus (ADV) and respiratory syncytial virus (RSV) infection.
    Fernández JA, Tapia L, Palomino MA, Larrañaga C, Peña M, Jaramillo H.
    Eur Cytokine Netw; 2005 Jun 15; 16(1):35-40. PubMed ID: 15809204
    [Abstract] [Full Text] [Related]

  • 17. Global gene expression profiling in infants with acute respiratory syncytial virus broncholitis demonstrates systemic activation of interferon signaling networks.
    Bucasas KL, Mian AI, Demmler-Harrison GJ, Caviness AC, Piedra PA, Franco LM, Shaw CA, Zhai Y, Wang X, Bray MS, Couch RB, Belmont JW.
    Pediatr Infect Dis J; 2013 Feb 15; 32(2):e68-76. PubMed ID: 23190772
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis.
    Fjaerli HO, Bukholm G, Skjaeret C, Holden M, Nakstad B.
    J Infect Dis; 2007 Aug 01; 196(3):394-404. PubMed ID: 17597454
    [Abstract] [Full Text] [Related]

  • 20. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus.
    Hull J, Rowlands K, Lockhart E, Moore C, Sharland M, Kwiatkowski D.
    J Infect Dis; 2003 Sep 15; 188(6):904-7. PubMed ID: 12964123
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.